STAT+: Gilead’s Dan O’Day is pharma’s most charming executive — but with his deals falling apart, charm may not be enough March 9, 2022 San Francisco Biotechnology Network News News Comments Off on STAT+: Gilead’s Dan O’Day is pharma’s most charming executive — but with his deals falling apart, charm may not be enough Gilead's Dan O’Day has charisma and charm. What he lacks lately are clear wins in drug development. Click to view original post BiotechMatt's TakebiotechnologycancerSTAT+